News & AnalysisInceptor Bio nets $37m Series AInceptor Bio, a biotechnology company, has secured $37 million in Series A financing.ByIris Dorbian19 May 2022•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsTechnologyBriefs